Skip to Content

Posts tagged with "Uncategorized"

  • Bubble Fusion Implodes

    The bubbles produced by sonication of liquids are weird things, and there’s no doubt that strikingly high temperatures and pressures can be produced in them (for strikingly short periods of time). The idea that they might be high enough to induce nuclear fusion has been around for years, and in 2002 a group at Oak… Read More
  • Wonder Drug, Indeed

    “Wonder Drug Inspires Deep, Unwavering Love of Pharmaceutical Companies”: “Many individuals today lack the deep, abiding affection for drug makers that is found in healthy people, such as myself,” Pfizer CEO Hank McKinnell said. “These tragic disorders are reaching epidemic levels, and as a company dedicated to promoti… Read More
  • Things Turn Nasty

    Back in 2003, I wrote about the excitement over PYY3-36, a peptide which showed some profound effects on feeding in animal models, but I wasn’t exactly jumping up and down: . . .You’re not going to be able to take this orally. It’s going to be i.v. or bust for some time, I’m afraid. There’s… Read More
  • Return of Neowater

    An interesting development in the comment threads to the “Nanotech Wonder Water” post was the appearance of Miguel Cizin, of DoCoop, makers of Neowater itself. He’s doing a good job looking out after his company’s name, and I’m glad to have him here. I’ve had a chance to look through their patent application, and… Read More
  • Dangerous Thoughts

    Not being a world-famous scientist, I wasn’t asked to contribute to the “Dangerous Ideas” festschrift (see the post below). Of course, I also don’t have their founder John Brockman as my literary agent, either. . .but if his people (or any other good agents!) call, I’ll definitely pick up the phone. But I̵… Read More
  • Grand Rounds

    Welcome to the latest iteration of Grand Rounds. On behalf of the greedy rapacious pharmaceutical industry, I’m glad to be hosting this week. Unfortunately for everyone, the research end of the G.R.P.I. is not immersed in the ceaseless flow of promotional swag that the medical community has come to know us for. So for you… Read More
  • A Vioxx Bomb Drops. Or Does It?

    You don’t see many articles in the medical literature titled “Expression of Concern”. But that’s how yesterday’s release from the New England Journal of Medicine starts out (PDF). The editors are expressing their concern over the published VIGOR trial data from 2000. It turns out that some time ago, the journal’s… Read More
  • The Bell Finally Tolls for Peter Rost

    I missed this last night, but Pfizer finally fired Peter Rost. (I’ve spoken about him and his situation at Pfizer here and here). He was hanging on in (well-paid) limbo due to a whistleblower suit he was involved in. The government declined to take part in the case this week, and the complaint was unsealed… Read More
  • A Man, A Book, and a Plan. Several Plans.

    So, what’s Kevin Trudeau up to these days? (Besides counting those great big stacks of money, that is). Back in August he was selling huge loads of his “Natural Cures” book, which is a rather huge load in and of itself, even though people seemed to be catching on to the fact that there are… Read More
  • Statin Showdown

    The American Heart Association meeting has been going on this week, and it’s one of the high-profile venues for cardiovascular research results. Today, among other things, came the details of a head-to-head trial (called, in standard cute-acronym style, IDEAL) of Pfizer’s Lipitor (atorvastatin) against Merck’s soon-to-be-generic Z… Read More